No abstract available
MeSH terms
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antibody-Dependent Cell Cytotoxicity
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / analysis
-
Biomarkers, Tumor / genetics
-
Carcinoma / diagnosis
-
Carcinoma / drug therapy
-
Carcinoma / genetics*
-
Drug Resistance, Neoplasm / genetics
-
Female
-
Gene Expression Regulation, Neoplastic* / drug effects
-
Humans
-
Immunohistochemistry
-
In Situ Hybridization
-
Ovarian Neoplasms / diagnosis
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / genetics*
-
Prognosis
-
Receptor, ErbB-2 / analysis
-
Receptor, ErbB-2 / genetics*
-
Receptor, ErbB-2 / immunology
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Receptor, ErbB-2
-
Trastuzumab